Cutaneous Pseudolymphoma Differential Diagnoses

Updated: Aug 14, 2019
  • Author: Gauri Panse, MBBS, MD; Chief Editor: William D James, MD  more...
  • Print
DDx

Diagnostic Considerations

Although overlap exists between drug-induced pseudolymphoma syndrome and drug-induced hypersensitivity syndrome, distinguishing these entities is important because drug-induced hypersensitivity syndrome has up to a 10% mortality rate and requires specific therapy. [6] If associated symptoms include lymphadenopathy, organomegaly, diffuse lymphadenopathy, and constitutional symptoms, drug-induced hypersensitivity syndrome should be considered.

Differential Diagnoses